Contributors

Contributors Philosopher-turned-biochemist Yves Barral has a hard time explaining where he’s from. He usually settles for: “I am, for sure, from this planet.” Born in Mexico City to African-born parents, he spent most of his childhood in various parts of France. He currently resides in Zürich, where he runs his own lab at the Swiss Federal Institute of Technology and studies the budding yeast, Saccharomyces cerevisiae, to understand how h

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Philosopher-turned-biochemist Yves Barral has a hard time explaining where he’s from. He usually settles for: “I am, for sure, from this planet.” Born in Mexico City to African-born parents, he spent most of his childhood in various parts of France. He currently resides in Zürich, where he runs his own lab at the Swiss Federal Institute of Technology and studies the budding yeast, Saccharomyces cerevisiae, to understand how highly dynamic systems of cellular components orchestrate division. “Many people go to science with the wish of curing diseases,” he says, but not him. He believes certain problems in biology, such as the prevention of aging, will forever remain unsolvable (see The Gates of Immortality). But science offers a silver lining: “At least, if we cannot change it, it’s a consolation to understand what it is.”

Michelle Fisher never thought she would be knee deep in science every month, but after more ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies